Evidence map›Paper›PMID 33248158›Full record

ReviewNeuroscience letters2021

Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19).

Doria M Gold, Steven L Galetta

Abstract readReview
In one paragraph

Review in Neuroscience letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Movement Disorders and SARS-CoV-2.Movement disorders clinical practice · 2023
    Article
  9. Covid-19 and its relation to the human eye: transmission, infection, and ocular manifestations.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Visual perception alterations in COVID-19: a preliminary study.International journal of ophthalmology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Imaging of the head and neck during the COVID19 pandemic.Operative techniques in otolaryngology--head and neck surgery · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Doria M GoldNYU Langone Medical Center, Department of Neurology, 222 E. 41(st) St., New York, NY, 10017, USA. Electronic address: Doria.gold@nyulangone.org.
Steven L GalettaNYU Langone Medical Center, Departments of Neurology and Ophthalmology, 222 E. 41(st) St., New York, NY, 10017, USA. Electronic address: Steven.galetta@nyulangone.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple neuro-ophthalmological manifestations have been described in association with COVID-19. These symptoms and signs may be the result of a range of pathophysiological mechanisms throughout the course from acute illness to recovery phase. Optic nerve dysfunction, eye movement abnormalities and visual field defects have been described.

Indexed as

COVID-19Cytokine Release SyndromeHumansNervous System DiseasesVision DisordersCOVID-19 infectionCranial nerve palsyDiplopiaMiller-Fisher variant Guillain Barre syndromeMyasthenia gravisNeuro-ophthalmologyOpsoclonusOptic neuritisOscillopsiaStrokeVenous sinus thrombosisVisual field defect

Identifiers

PMID33248158
PMCPMC7687583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.